Black Diamond Therapeutics (BDTX) Other Gross PP&E Adjustments (2018 - 2025)
Black Diamond Therapeutics' Other Gross PP&E Adjustments history spans 6 years, with the latest figure at -$15.0 million for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 38.04% year-over-year to -$15.0 million; the TTM value through Dec 2025 reached -$15.0 million, up 38.04%, while the annual FY2025 figure was -$15.0 million, 38.04% up from the prior year.
- Other Gross PP&E Adjustments reached -$15.0 million in Q4 2025 per BDTX's latest filing, down from -$14.1 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$10.5 million in Q2 2021 to a low of -$25.2 million in Q3 2021.
- Average Other Gross PP&E Adjustments over 3 years is -$17.0 million, with a median of -$15.7 million recorded in 2025.
- Peak YoY movement for Other Gross PP&E Adjustments: crashed 12918.52% in 2021, then surged 38.04% in 2025.
- A 3-year view of Other Gross PP&E Adjustments shows it stood at -$25.2 million in 2021, then grew by 4.06% to -$24.2 million in 2024, then soared by 38.04% to -$15.0 million in 2025.
- Per Business Quant, the three most recent readings for BDTX's Other Gross PP&E Adjustments are -$15.0 million (Q4 2025), -$14.1 million (Q3 2025), and -$14.9 million (Q2 2025).